Mariaconcetta Durante Selected Research

S-(2-guanidylethyl)isothiourea

10/2021	The Histamine H4 Receptor Participates in the Anti-Neuropathic Effect of the Adenosine A3 Receptor Agonist IB-MECA: Role of CD4+ T Cells.
1/2017	Histamine H4 receptor agonist-induced relief from painful peripheral neuropathy is mediated by inhibition of spinal neuroinflammation and oxidative stress.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mariaconcetta Durante Research Topics

Disease

4	Neuralgia (Stump Neuralgia) 10/2021 - 01/2017
4	Inflammation (Inflammations) 10/2020 - 01/2016
4	Fibrosis (Cirrhosis) 10/2020 - 01/2016
3	Glaucoma 02/2019 - 01/2016
2	Hyperalgesia 10/2021 - 01/2017
2	Ischemia 01/2021 - 01/2018
2	Body Weight (Weight, Body) 01/2021 - 01/2018
2	Ocular Hypertension (Glaucoma, Suspect) 02/2019 - 01/2017
2	Immune System Diseases (Immune Disorders) 01/2019 - 01/2016
2	Metabolic Diseases (Metabolic Disease) 01/2019 - 01/2018
2	Airway Remodeling 01/2019 - 01/2016
1	Pain (Aches) 10/2021
1	Hypersensitivity (Allergy) 01/2021
1	Arthritis (Polyarthritis) 10/2020
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2020
1	Obesity 01/2019
1	Overweight 01/2019
1	Chronic Disease (Chronic Diseases) 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2018
1	Transient Ischemic Attack 01/2018
1	Brain Ischemia (Cerebral Ischemia) 01/2018
1	Necrosis 01/2017
1	Neuroinflammatory Diseases 01/2017
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2017
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2016
1	Hyperplasia 01/2016

Drug/Important Bio-Agent (IBA)

4	Bleomycin (Blenoxane)FDA LinkGeneric 10/2020 - 01/2016
4	Histamine H4 ReceptorsIBA 01/2019 - 01/2016
3	Interleukin-10 (Interleukin 10)IBA 10/2021 - 01/2019
3	Histamine (Histamine Dihydrochloride)FDA Link 02/2019 - 01/2016
3	LigandsIBA 01/2019 - 01/2016
2	Purinergic P1 Receptors (Adenosine Receptor)IBA 10/2021 - 01/2021
2	S-(2-guanidylethyl)isothioureaIBA 10/2021 - 01/2017
2	LipidsIBA 01/2021 - 01/2018
2	FructoseIBA 01/2021 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2018
2	Peroxidase (Myeloperoxidase)IBA 01/2019 - 01/2016
2	1- ((5- chloro- 1H- indol- 2- yl)carbonyl)- 4- methylpiperazineIBA 01/2019 - 01/2018
2	CytokinesIBA 01/2018 - 01/2016
2	CollagenIBA 01/2017 - 01/2016
1	N(6)- (3- iodobenzyl)- 5'- N- methylcarboxamidoadenosineIBA 10/2021
1	Interleukin-6 (Interleukin 6)IBA 10/2021
1	Histamine Receptors (Histamine Receptor)IBA 10/2021
1	Adenosine (Adenocard)FDA LinkGeneric 01/2021
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2021
1	Insulin (Novolin)FDA Link 01/2021
1	Pharmaceutical PreparationsIBA 10/2020
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 10/2020
1	Carbonic Anhydrase InhibitorsIBA 10/2020
1	ciproxifanIBA 02/2019
1	6- ((3- cyclobutyl- 2,3,4,5- tetrahydro- 1H- 3- benzazepin- 7- yl)oxy)- N- methyl- 3- pyridinecarboxamideIBA 02/2019
1	carbomerIBA 02/2019
1	Olive OilIBA 01/2019
1	AdiponectinIBA 01/2019
1	SugarsIBA 01/2018
1	Melatonin Receptors (Melatonin Receptor)IBA 01/2018
1	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 01/2018
1	Neuroprotective AgentsIBA 01/2018
1	MonosaccharidesIBA 01/2018
1	tagatose (D-tagatose)IBA 01/2018
1	InterleukinsIBA 01/2017
1	1,2,5-oxadiazole 2-oxideIBA 01/2017
1	Thiobarbituric Acid Reactive SubstancesIBA 01/2016
1	indium-bleomycinIBA 01/2016
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2016
1	8-Hydroxy-2'-DeoxyguanosineIBA 01/2016
1	Carbonic Anhydrases (Carbonic Anhydrase)IBA 01/2016
1	Malondialdehyde (Propanedial)IBA 01/2016

Therapy/Procedure

2	Therapeutics 02/2019 - 01/2019
1	Intravenous Administration 10/2021
1	Mediterranean Diet 01/2019